Download full report with analyst certification and important disclosures
Jul 14 2025, 14:30 IST/BST
We expect CRH’s Q2 results to reveal continued growth in sales, adjusted EBITDA and EPS. Indeed, we believe that CRH’s recent record on growth and improving returns suggest that its strategic position and capital allocation are working in tandem to deliver further value creation. The stock, in our view, remains strongly undervalued.
Jul 14 2025, 14:30 IST/BST